Physician Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Physician Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Baylor Institute for Immunology Research
Success reported in treating children with juvenile arthritis
June 22nd, 2005
In the May 2, 2005, issue of The Journal of Experimental Medicine, Virginia Pascual, MD, and Jacques Banchereau, PhD, from the Baylor Institute for Immunology Research in Dallas (BIIR), reported on the successful treatment of children with systemic onset juvenile idiopathic arthritis (SoJIA). The findings are highly significant for SoJIA patients for whom previous therapies have failed. Approximately 250,000 children in the U.S. suffer from juvenile arthritis. SoJIA accounts for about 10% of all juvenile arthritis cases with unknown causes. Early symptoms, which often go undiagnosed, may include fever and a rash. As the...
Source: Physician Law Weekly (2005-06-22)
|
